Names | |
---|---|
IUPAC name
(4′,5,7-Trihydroxyflavone)-(3′→8)-(4′,5,7-trihydroxyflavone)
| |
Systematic IUPAC name
8-[5-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | |
Other names
Didemethyl-ginkgetin
3′,8″-Biapigenin | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider |
|
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C30H18O10 | |
Molar mass | 538.464 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Amentoflavone is a biflavonoid (bis-apigenin coupled at 8 and 3′ positions, or 3′,8″-biapigenin) constituent of a number of plants including Ginkgo biloba, Chamaecyparis obtusa (hinoki), Biophytum sensitivum, Selaginella tamariscina,[1] Hypericum perforatum (St. John's Wort)[2] and Xerophyta plicata.[3]
Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body.[4] It is also an inhibitor of human cathepsin B.[2]
Amentoflavone has a variety of in vitro activities including antimalarial activity,[5] anticancer activity (which may, at least in part, be mediated by its inhibition of fatty acid synthase),[6][7][8] and antagonist activity at the κ-opioid receptor (Ke = 490 nmol L−1)[9] as well as activity at the allosteric benzodiazepine site of the GABAA receptor as a negative allosteric modulator.[10]
((cite journal))
: CS1 maint: date and year (link)
Flavones and their conjugates | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aglycones |
| ||||||||||||
Glycosides |
| ||||||||||||
Acetylated | |||||||||||||
Sulfated glycosides | Theograndin I and II | ||||||||||||
Polymers | |||||||||||||
Drugs |
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|